GLP-1 receptor agonists (RAs), more commonly known as semaglutide and by their brand names Ozempic and Wegovy, have made waves in the healthcare industry. More people with Type II diabetes are taking these medications in hopes to reduce the chances of debilitating diseases and complications such as nonalcoholic fatty liver, heart, and kidney disease. Although GLP-1 agonists were originally created to help control insulin levels for diabetics, they have been found to help with another deadly condition – obesity. While people take their weekly shot to control glucose and insulin levels, reduce appetite, and control hormones, they sometimes get another surprise benefit from these medications – enhanced fertility.
READ MORE 
)
)
)
)
)
)
)
)
)